Parmax Pharma Ltd

📅 Parmax Pharma Reschedules Board Meeting to Review Financial Results

- Board meeting rescheduled from Nov 14, 2024, to Nov 15, 2025.

- Agenda includes approval of unaudited financial results for Q2 & H1 ending Sept 30, 2025.

- Change due to unavoidable reasons.

- Announcement made to BSE (Script Code: 540359).